BiotechTubeBiotechTube
Home/Pipeline/CHRONOS-PD Platform

CHRONOS-PD Platform

Parkinson's Disease

ResearchActive

Key Facts

Indication
Parkinson's Disease
Phase
Research
Status
Active
Company
Grifols

About Grifols

Grifols is a Spanish multinational pharmaceutical and chemical company that develops plasma-derived medicines and other biopharmaceuticals for patients with chronic and rare diseases. Founded in 1909 in Barcelona, the company has grown into a global leader in plasma collection and fractionation, with operations spanning biopharma, diagnostics, bio supplies, and hospital healthcare solutions. The company is publicly traded and has been recognized by TIME magazine and Forbes as one of the world's best companies and employers for multiple consecutive years.

View full company profile

Therapeutic Areas

ImmunologyHepatologyPulmonologyHematologyNeurologyInfectious DiseasesIntensive Care

Other Parkinson's Disease Drugs

DrugCompanyPhase
ABBV-951AbbViePhase 3
UCB0107UCBPhase 1
StalevoOrion CorporationApproved
Comtan/ComtessOrion CorporationApproved
GT-001 (Gene Therapy)Sumitomo PharmaPhase 1/2
CREXONT (Carbidopa/Levodopa)Amneal PharmaceuticalsApproved
BIIB122/DNL151Denali TherapeuticsPhase 3
ABBV-0805BioArctic ABPhase 1
BAN1202BioArctic ABPreclinical
ARV-102ArvinasPhase 1
AAV-GADMeiraGTxPreclinical/Phase 1
Not SpecifiedMinerva NeurosciencesClinical Stage